Gleneagles Global Health City forms task force to tackle cases of mucormycosis

The team will treat COVID-19 patients with the condition.

June 04, 2021 12:01 am | Updated 12:01 am IST - CHENNAI

Gleneagles Global Health City (GGHC) has formed a 27-member mucormycosis task force to treat COVID-19 patients with the condition.

The team comprises eye surgeons, ENT specialists, plastic surgeons, neurosurgeons, infectious disease experts, internal medicine consultants, diabetologists, radiologists, pathologists and dental maxillo facial surgeons.

Director of Infections Diseases and Infection Control Subramanian Swaminathan said the hospital had experience handling such instances, and this had better prepared them for the current scenario. Ashwin Karuppan V., consultant in the Department of Internal Medicine and Diabetology, said with the outbreak of COVID-19, the number of cases of mucormycosis had increased, demanding timely attention of a multi-disciplinary team.

Senior consultant of Histopathology Mouleeswaran said the infection had been noticed earlier in patients who had undergone organ transplant, besides those with uncontrolled diabetes and immuno-compromised patients. “We give reports within a few minutes and the final report within a day to assist physicians, surgeons and infectious disease specialists,” he said.

Chief executive officer of the hospital Alok Khullar said, “Since the number of patients infected is increasing day-by-day, we are trying to ensure that we have a protocol to provide world-class treatment and excellent clinical outcomes.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.